RecruitingPhase 3NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Sponsor: Greenwich LifeSciences, Inc.
Duarte, CA · Fullerton, CA · Irvine, CA · +48 more sites
3 recruiting breast cancer studies with a site in Fullerton, CA.
Sponsor: Greenwich LifeSciences, Inc.
Duarte, CA · Fullerton, CA · Irvine, CA · +48 more sites
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Anaheim, CA · Fullerton, CA · +103 more sites
Sponsor: Jonsson Comprehensive Cancer Center
Fullerton, CA · Los Alamitos, CA · Los Angeles, CA · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.